extraordinari
demand
manag
pandem
disrupt
world
abil
care
patient
thorac
malign
hospit
popul
increas
hospit
resourc
deplet
abil
provid
surgic
care
progress
restrict
forc
surgeon
priorit
among
cancer
popul
repres
multipl
cancer
surgic
research
organ
come
togeth
provid
guid
triag
patient
thorac
malign
impact
evolv
hospit
pandem
forc
hospit
progress
reduc
surgic
volum
minim
diseas
transmiss
within
hospit
preserv
human
person
protect
equip
ppe
resourc
need
care
patient
respons
mani
hospit
abruptli
reduc
elimin
elect
surgeri
burden
hospit
increas
procedur
improv
surviv
may
similarli
reduc
elimin
ie
semielect
urgent
perhap
emerg
oper
cancer
patient
surgeri
may
delay
month
even
year
without
neg
consequ
howev
scenario
failur
perform
indic
cancer
surgeri
time
fashion
may
long
term
implic
patient
survivorship
signific
perman
deficit
qualiti
life
therefor
cancer
patient
oncolog
team
treat
like
face
difficult
decis
suboptim
manag
strategi
thorac
oncolog
decis
complic
fact
patient
lung
esophag
thorac
malign
would
consid
high
risk
group
poor
outcom
advanc
age
emphysema
heart
diseas
indic
therapeut
procedur
impair
lung
function
ie
lung
isol
remov
lung
tissu
expos
clinic
team
aerosol
viral
load
bronchoscopi
doublelumen
endotrach
tube
placement
airway
surgeri
laparoscopi
possibl
lung
surgeri
particularli
parenchym
lung
leak
assembl
document
offer
guidanc
intend
facilit
difficult
decis
care
patient
thorac
malign
pandem
tabl
much
impact
timelin
durat
risk
ultim
recoveri
pandem
remain
unknown
effort
give
context
triag
guid
sever
assumpt
made
risk
nosocomi
infect
patient
clinician
infect
hospit
competit
resourc
surgic
medic
patient
increas
proport
preval
hospit
patient
durat
restrict
elect
surgeri
last
approxim
month
facil
progress
phase
care
restrict
variabl
surgeon
prepar
rapid
chang
hospit
statu
ie
consid
elig
surgeri
could
perform
soon
possibl
surgic
leadership
provid
daili
updat
regard
hospit
popul
resourc
statu
nuanc
patient
manag
approach
ie
proceed
surgeri
delay
surgeri
pursu
altern
treatment
impact
risk
toler
patient
surgeon
ideal
tradit
cancer
treatment
logist
feasibl
patient
care
plan
made
input
group
clinician
expertis
thorac
malign
ie
case
confer
tumor
board
encourag
use
multidisciplinari
strategi
guidanc
appropri
individu
hospit
clinic
set
sever
consider
may
caus
group
consensu
approach
differ
propos
tabl
risk
delay
may
specif
captur
outlin
descriptor
ie
tumor
may
aggress
growth
kinet
histolog
resourc
limit
clinician
suppli
facil
affect
surgic
medic
radiat
oncolog
depart
may
pose
heterogen
restrict
hospit
hospit
clinician
need
keep
mind
import
concept
social
distanc
modifi
manag
limit
number
visit
hospit
reason
addit
durat
surgic
volum
restrict
unknown
month
presum
patient
delay
defer
track
ie
patient
registri
databas
consider
databas
includ
follow
indic
reassess
period
delay
could
influenc
care
plan
ie
follow
ct
scan
extrem
select
access
imag
like
increasingli
restrict
increas
preval
indic
case
prioriti
ie
first
group
second
group
third
group
reschedul
restrict
lift
best
care
patient
whose
surviv
may
impact
addit
delay
preoper
evalu
like
impact
ie
pulmonari
function
test
preoper
screen
evolv
survey
symptom
temperatur
assess
possibl
select
test
avail
possibl
strategi
outlin
document
could
replac
understand
uniqu
challeng
pose
within
countri
state
healthcar
environ
evolv
document
intend
guid
clinic
scenario
epidem
pandem
transpar
regard
potenti
risk
defer
proceed
oper
remain
prioriti
surgeon
discuss
decis
individu
patient
multidisciplinari
team
encourag
develop
altern
treatment
strategi
surgic
resect
declin
infeas
initi
extens
american
colleg
surgeon
commiss
cancer
time
right
decis
becom
easier
impact
decis
evapor
one
time
hope
document
facilit
time
execut
sure
increasingli
difficult
decis
smaller
institut
studi
reveal
clear
associ
diagnosistreat
interv
longterm
outcom
patient
esophag
cancer
delay
greater
week
neoadjuv
therapi
surgeri
esophag
cancer
associ
decrement
longterm
surviv
b
avail
altern
treatment
may
vari
across
health
system
time
decis
pursu
altern
treatment
must
balanc
risk
defer
altern
treatment
chemotherapi
radiat
risk
exposur
patient
staff
infect
phase
altern
treatment
predomin
consid
patient
felt
harm
delay
ie
first
column
tabl
c
time
write
risk
mortal
infect
felt
higher
among
patient
receiv
chemotherapi
data
incred
limit
cancer
patient
china
although
accuraci
clinic
stage
examin
may
enhanc
invas
stage
procedur
magnitud
surviv
benefit
superior
stage
may
consid
modest
set
strain
resourc
potenti
exposur
risk
clinic
staff
stage
procedur
bronchoscopi
mediastinoscopi
treat
patient
base
exclus
noninvas
stage
evalu
ie
imag
alon
reason
e
procedur
current
felt
associ
particularli
high
potenti
dissemin
done
select
ideal
patient
screen
activ
infect
f
incomplet
data
compar
surgeri
sabr
earli
stage
lung
cancer
patient
elig
surgeri
observ
data
like
bias
patient
surgic
candid
suggest
modest
surviv
advantag
surgeri
higher
surviv
g
among
presum
highli
select
patient
salvag
resect
associ
reason
survivorship
definit
nonsurg
therapi
esophag
cancer
particularli
patient
good
respons
imag
h
recommend
patient
delay
would
like
compromis
surviv
ie
first
column
phase
section
